News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
183 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25546)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (164)
2 (249)
3 (156)
5 (7)
6 (230)
7 (240)
8 (320)
9 (291)
10 (99)
11 (2)
12 (4)
13 (247)
14 (235)
15 (231)
16 (238)
17 (128)
18 (5)
19 (4)
20 (183)
21 (221)
22 (223)
23 (239)
24 (116)
25 (4)
26 (4)
27 (246)
28 (244)
29 (262)
30 (310)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Bulletin from the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
The annual general meeting in InDex Pharmaceuticals Holding AB (publ) was held on Monday 20 April 2020 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm, Sweden
April 20, 2020
·
3 min read
BioMidwest
American Lung Association: Universal COVID-19 Antibody Testing Urgently Needed
The COVID-19 pandemic has resulted in unprecedented rates of lung infections and deaths in modern history.
April 20, 2020
·
3 min read
Business
Spectroscopy® Announces Markita Landry, Ph.D., as the Winner of the 2020 Emerging Leader in Molecular Spectroscopy
Spectroscopy®, is proud to announce that Markita Landry, Ph.D., has been named the winner of the 2020 Emerging Leader in Molecular Spectroscopy Award.
April 20, 2020
·
2 min read
Business
Radius Health to Announce First Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday May 7, 2020
Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Thursday, May 7, 2020.
April 20, 2020
·
1 min read
BioMidwest
Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus
Assertio Therapeutics, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced the date of its 2020 Annual Meeting, which will be held as a virtual meeting on May 19, 2020.
April 20, 2020
·
11 min read
Business
AANA Applauds Gov. Cuomo’s Call for Hazard Pay for Front-Line Healthcare Workers
New York Gov. Andrew Cuomo called on the federal government to provide pay bonuses to front-line healthcare workers.
April 20, 2020
·
2 min read
Biotech Beach
MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of glioblastoma.
April 20, 2020
·
7 min read
Policy
Coronavirus (COVID-19) Update: Daily Roundup - April 20, 2020
The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic
April 20, 2020
·
3 min read
Biotech Bay
Smart Inhalers Market - Demand for Smart Inhalers Gains Pace to Curb Respiratory Disorders
TMR Research announces a new report on the global smart inhalers market.
April 20, 2020
·
3 min read
Policy
First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center Using Stemedica Ischemia-Tolerant Allogeneic Mesenchymal Bone Marrow Cells
A single patient, emergency Investigational New Drug use was cleared by the U.S. Food and Drug Administration for the treatment of severe lung injury due to COVID-19 at the Providence Saint John’s Health Center, Santa Monica, CA with intravenous administration of ischemia-tolerant allogeneic mesenchymal bone marrow cells manufactured by Stemedica Cell Technologies, Inc.
April 20, 2020
·
4 min read
Previous
12 of 19
Next